Analysis of glycoconjugate structure/functions requires specialized expertise from various disciplines. Many of these tools and approaches are not only difficult, but also require expensive and complex equipment. We have established our Shared Resource Core to not only contain the components that are most essential for the aims of this PEG, but also that build upon the unique strengths of our participating investigators. Each sub-Core is detailed in their separate sections. Sub-Core 01 - Mass Spectrometry -Drs. van Eyk and Zhang are leaders in mass spectrometric analysis of proteins and glycoproteins. The Core is extraordinarily well equipped. The Core's offerings include: 1) Identification of proteins;2) global quantification of N-linked or O-linked glycoproteins using solidphase extraction of glycopeptides;3) Lectin affinity/MS analyses;4) Monitoring changes in glycosylation by lectin microarrays;5) The use of """"""""Click"""""""" chemistry for analyses of metabolically produced glycoconjugates;6)Glycan profiling by MALDI-MS"""""""" (AXIMA-Resonance) and GlycanAnalyser. 7) Cell surface capture technology for isolation of glycoproteins;2) Targeted capture of soluble glycoproteins from cytoplasm or extracellular environment;3) MRM MS/MS assays for targeted quantification ofglycoproteins and glycosylation sites. Sub-Core C2 - NMR - When possible, glycan structure is best determined by NMR. Dr. Allen Bush is a leading expert in the structural analysis of glycans by NMR. His sub-Core supports the PEG by offering structural expertise for oligosaccharides, polysaccharides, glycopeptides, small glycoproteins and glycolipids. State of the art NMR equipment and methods are available in this sub-Core. Sub-Core C3 - Chemistry - Dr. Kevin Yarema is a leading chemical glycobiologist. His sub-Core will support the PEGs by: 1) providing sugar analogs for """"""""metabolic glycoengineering"""""""" (eg. SCFA-hexosamines); 2) performing custom synthesis of inhibitors (eg. D-PDMP, TMG), azido sugars and sugar nucleotides, glycan-tagging tools and other small molecules. Sub-Core 04 - 0-GlcNAc Resources - Drs. Hart and Zachara are leaders in the analysis of 0-GlcNAc. In support of the PEGs we offer: 1) Tools for detecting 0-GlcNAc, OGT and OGA;2) Develop site-specific 0-GlcNAc antibodies;3) Provide synthetic 0-GlcNAc peptides for antibody production and MS standards;4) Assays for OGT and OGA activity;5) Quantitation of sugar nucleotides &nucleotides;6) Assist with site mapping and quantification on single proteins or globally. This Shared Resource provides key technologies to allow rapid advancement of glycoscience research critical to the mission of the NHLBI.

Public Health Relevance

The Study of the roles of glycoconjugates in disease requires multifaceted approaches. This Shared Resource Core provides state-of-the-art tools, methods and expertise to support not only the study of cardiovascular disease, but also to support the broader goals of the PEGs. Each sub-Core builds upon the unique strengths of our PEG and offers tools and reagents that are not typically available to most researchers.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
5P01HL107153-03
Application #
8477281
Study Section
Special Emphasis Panel (ZHL1-CSR-H)
Project Start
Project End
Budget Start
2013-06-01
Budget End
2014-05-31
Support Year
3
Fiscal Year
2013
Total Cost
$539,362
Indirect Cost
$182,639
Name
Johns Hopkins University
Department
Type
DUNS #
001910777
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Harosh-Davidovich, Shani Ben; Khalaila, Isam (2018) O-GlcNAcylation affects ?-catenin and E-cadherin expression, cell motility and tumorigenicity of colorectal cancer. Exp Cell Res 364:42-49
Drake, Walter R; Hou, Ching-Wen; Zachara, Natasha E et al. (2018) New use for CETSA: monitoring innate immune receptor stability via post-translational modification by OGT. J Bioenerg Biomembr 50:231-240
Höti, Naseruddin; Yang, Shuang; Hu, Yingwei et al. (2018) Overexpression of ? (1,6) fucosyltransferase in the development of castration-resistant prostate cancer cells. Prostate Cancer Prostatic Dis 21:137-146
Hashimoto, Toru; Kim, Grace E; Tunin, Richard S et al. (2018) Acute Enhancement of Cardiac Function by Phosphodiesterase Type 1 Inhibition. Circulation 138:1974-1987
Rainer, Peter P; Dong, Peihong; Sorge, Matteo et al. (2018) Desmin Phosphorylation Triggers Preamyloid Oligomers Formation and Myocyte Dysfunction in Acquired Heart Failure. Circ Res 122:e75-e83
Groves, Jennifer A; Zachara, Natasha E (2017) Characterization of tools to detect and enrich human and mouse O-GlcNAcase. Glycobiology :
Yang, Shuang; Hu, Yingwei; Sokoll, Lori et al. (2017) Simultaneous quantification of N- and O-glycans using a solid-phase method. Nat Protoc 12:1229-1244
Yang, Weiming; Shah, Punit; Hu, Yingwei et al. (2017) Comparison of Enrichment Methods for Intact N- and O-Linked Glycopeptides Using Strong Anion Exchange and Hydrophilic Interaction Liquid Chromatography. Anal Chem 89:11193-11197
Grima, Jonathan C; Daigle, J Gavin; Arbez, Nicolas et al. (2017) Mutant Huntingtin Disrupts the Nuclear Pore Complex. Neuron 94:93-107.e6
Groves, Jennifer A; Maduka, Austin O; O'Meally, Robert N et al. (2017) Fatty acid synthase inhibits the O-GlcNAcase during oxidative stress. J Biol Chem 292:6493-6511

Showing the most recent 10 out of 137 publications